Clinical Trials Logo

Clinical Trial Summary

Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including : - In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows. - Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana. As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06345976
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Not yet recruiting
Phase
Start date May 2024
Completion date May 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04495218 - NGS Panel of Incomplete Forms of Ocular Albinism
Completed NCT00001153 - Visual Function and Ocular Pigmentation in Albinism N/A
Completed NCT03959605 - Genetic Determinant of Foveolar Hypoplasia in Parents of Albinos Children